Momotaro Gene Competitors and Similar CompaniesClear all
Momotaro Gene's competitors and similar companies include Burning Rock Biotech, Immunetune, Hubro Therapeutics and Stamford Pharmaceuticals.
 Momotaro Gene Momotaro Gene is a company developing next-generation cancer therapeutics by gene therapy. |  Burning Rock Biotech Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology. |  Immunetune Immunetune is a biotech company that develops personalized DNA-based vaccines to treat highly mutated cancer types, including melanoma, lung, and colon cancer. |  Hubro Therapeutics Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer. |  Stamford Pharmaceuticals Stamford Pharmaceuticals is a clinical stage immunology and inflammation-focused company developing gene therapies and biologics. | |
Founding Date | Founding Date 2007 | Founding Date 2014 | Founding Date 2016 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Public | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Guang Zhou, CN HQ Beijing, CN Shanghai, CN Irvine, US | Locations Leiden, NL HQ | Locations Oslo, NO HQ | Locations Greenwich, US HQ |
Employees | Employees N/A | Employees 674 | Employees 2 | Employees 3 | Employees 4 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥539.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) kr53.6k (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥114.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥424.7m (FY, 2025) | Gross profit N/A | Gross profit kr53.6k (FY, 2021) | Gross profit N/A |
Net income | Net income N/A | Net income (¥55.3m) (FY, 2025) | Net income N/A | Net income (kr7.5m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 9.6m | Total funding raised $ 149.2m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Burning Rock Biotech
HQ
Guang Zhou, CN
Employees
674
Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology.
View companyImmunetune
HQ
Leiden, NL
Employees
2
Immunetune is a biotech company that develops personalized DNA-based vaccines to treat highly mutated cancer types, including melanoma, lung, and colon cancer.
View companyHubro Therapeutics
HQ
Oslo, NO
Hubro Therapeutics is a company that develops proprietary neo-peptide technology platforms and immunotherapies for the treatment of cancer.
View companyStamford Pharmaceuticals
HQ
Greenwich, US
Employees
4
Stamford Pharmaceuticals is a clinical stage immunology and inflammation-focused company developing gene therapies and biologics.
View company